FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Wright

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Blood Pressure

Procedures

Injections, Intraventricular

Anatomy

Physiology

Maze Learning

Co-author Network

Publications

TOP 3
Alene T McCoy; Gary Wayman; John W Wright; Mingyan Zhu; Suzanne M Appleyard; Caroline C Benoist; Jyote M Bule-Ghogare; Leen H Kawas; Joseph W Harding
Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.
John W Wright; Joseph W Harding
The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.
Leen H Kawas; Alene T McCoy; John W Wright; Brent J Yamamoto; Joseph W Harding
Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Wright (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alene T McCoy; Gary Wayman; John W Wright; Mingyan Zhu; Suzanne M Appleyard; Caroline C Benoist; Jyote M Bule-Ghogare; Leen H Kawas; Joseph W Harding
Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.
The Journal of pharmacology and experimental therapeutics 2013;344(1):141-54.
2013: John W Wright; Joseph W Harding
The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.
Pflügers Archiv : European journal of physiology 2013;465(1):133-51.
2012: Leen H Kawas; Alene T McCoy; John W Wright; Brent J Yamamoto; Joseph W Harding
Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers.
The Journal of pharmacology and experimental therapeutics 2012;340(3):539-48.
2012: John W Wright; Joseph W Harding
Importance of the brain Angiotensin system in Parkinson's disease.
Parkinson's disease 2012;2012():860923.
2012: John W Wright; Shigehiko Mizutani; Joseph W Harding
Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension.
International journal of hypertension 2012;2012():124758.
2011: Leen H Kawas; John W Wright; Brent J Yamamoto; Joseph W Harding
Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity.
The Journal of pharmacology and experimental therapeutics 2011;339(2):509-18.
2011: Caroline C Benoist; Gary Wayman; John W Wright; Mingyan Zhu; Suzanne M Appleyard; Joseph W Harding
Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs.
The Journal of pharmacology and experimental therapeutics 2011;339(1):35-44.
2011: John W Wright; Joseph W Harding
Brain renin-angiotensin--a new look at an old system.
Progress in neurobiology 2011;95(1):49-67.
2010: John W Wright; Joseph W Harding
The brain RAS and Alzheimer's disease.
Experimental neurology 2010;223(2):326-33.
2010: B J Yamamoto; P D Elias; J A Masino; B D Hudson; A T McCoy; Z J Anderson; Michael D Varnum; MF Sardinia; John W Wright; Joseph W Harding
The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor.
The Journal of pharmacology and experimental therapeutics 2010;333(1):161-73.
2009: John W Wright; Peter C Meighan; Travis E Brown; Roberta V Wiediger; Barbara A Sorg; Joseph W Harding
Habituation-induced neural plasticity in the hippocampus and prefrontal cortex mediated by MMP-3.
Behavioural brain research 2009;203(1):27-34.
2009: Wendy L Wilson; Christine Munn; Ryan C Ross; Joseph W Harding; John W Wright
The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): effects on spatial memory.
Brain research 2009;1272():25-31.
2009: John W Wright; Joseph W Harding
Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction.
Neural plasticity 2009;2009():579382.
2008: John W Wright; Joseph W Harding
The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2008;9(4):226-37.
2008: Travis E Brown; Melissa R Forquer; Joseph W Harding; John W Wright; Barbara A Sorg
Increase in matrix metalloproteinase-9 levels in the rat medial prefrontal cortex after cocaine reinstatement of conditioned place preference.
Synapse (New York, N.Y.) 2008;62(12):886-9.
2008: John W Wright; Shigehiko Mizutani; Joseph W Harding
Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.
Heart failure reviews 2008;13(3):367-75.
2008: Kelby L Holtfreter; Eric S Murphy; Joseph W Harding; John W Wright
Effects of suprachiasmatic nucleus lesions on habituation of the head-shake response.
Neuroscience letters 2008;439(2):203-7.
2008: Mikel L Olson; Peter C Meighan; Travis E Brown; Aaron L Asay; Caroline C Benoist; Joseph W Harding; John W Wright
Hippocampal MMP-3 elevation is associated with passive avoidance conditioning.
Regulatory peptides 2008;146(1-3):19-25.
2008: John W Wright; Brent J Yamamoto; Joseph W Harding
Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.
Progress in neurobiology 2008;84(2):157-81.
2007: Peter C Meighan; Starla E Meighan; Christopher J Davis; John W Wright; Joseph W Harding
Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses.
Journal of neurochemistry 2007;102(6):2085-96.
2007: Ranjita J Kokje; Wendy L Wilson; Travis E Brown; Vardan T Karamyan; John W Wright; Robert C Speth
Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis.
Hypertension 2007;49(6):1328-35.
2007: John W Wright; Travis E Brown; Joseph W Harding
Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory.
Neural plasticity 2007;2007():73813.
2006: John W Wright; Starla E Meighan; Eric S Murphy; Kelby L Holtfreter; Christopher J Davis; Mikel L Olson; Caroline C Benoist; Kalyani Muhunthan; Joseph W Harding
Habituation of the head-shake response induces changes in brain matrix metalloproteinases-3 (MMP-3) and -9.
Behavioural brain research 2006;174(1):78-85.
2006: Christopher J Davis; Peter C Meighan; Ping Taishi; James M Krueger; Joseph W Harding; John W Wright
REM sleep deprivation attenuates actin-binding protein cortactin: a link between sleep and hippocampal plasticity.
Neuroscience letters 2006;400(3):191-6.
2006: Starla E Meighan; Peter C Meighan; Papiya Choudhury; Christopher J Davis; Mikel L Olson; Peter A Zornes; John W Wright; Joseph W Harding
Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity.
Journal of neurochemistry 2006;96(5):1227-41.
2006: Christopher J Davis; Enikö A Kramár; Alok De; Peter C Meighan; Steven M Simasko; John W Wright; Joseph W Harding
AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation.
Neuroscience 2006;137(4):1369-79.
2005: Wendy L Wilson; Bernard P Roques; Catherine Llorens-Cortes; Robert C Speth; Joseph W Harding; John W Wright
Roles of brain angiotensins II and III in thirst and sodium appetite.
Brain research 2005;1060(1-2):108-17.
2005: Eric S Murphy; Joseph W Harding; Kalyani Muhunthan; Kelby L Holtfreter; John W Wright
Role of mitogen-activated protein kinases during recovery from head-shake response habituation in rats.
Brain research 2005;1050(1-2):170-9.
2004: John W Wright; Eric S Murphy; Itoro E Elijah; Kelby L Holtfreter; Christopher J Davis; Mikel L Olson; Kalyani Muhunthan; Joseph W Harding
Influence of hippocampectomy on habituation, exploratory behavior, and spatial memory in rats.
Brain research 2004;1023(1):1-14.
2004: Anthony L Albiston; Eric S Pederson; Peta Burns; Brett Purcell; John W Wright; Joseph W Harding; Frederick Mendelsohn; Richard S Weisinger; Siew Yeen Chai
Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms.
Behavioural brain research 2004;154(1):239-43.
2004: John W Wright; Jeremy A Alt; Gary D Turner; James M Krueger
Differences in spatial learning comparing transgenic p75 knockout, New Zealand Black, C57BL/6, and Swiss Webster mice.
Behavioural brain research 2004;153(2):453-8.
2004: John W Wright; Joseph W Harding
The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory.
Progress in neurobiology 2004;72(4):263-93.
2004: Mikel L Olson; Emily A Olson; Jacob H Qualls; Jessica J Stratton; Joseph W Harding; John W Wright
Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits.
Peptides 2004;25(2):233-41.
2003: Christopher J Davis; Joseph W Harding; John W Wright
REM sleep deprivation-induced deficits in the latency-to-peak induction and maintenance of long-term potentiation within the CA1 region of the hippocampus.
Brain research 2003;973(2):293-7.
2003: John W Wright; Enikö A Kramár; Elizabeth D T Myers; Christopher J Davis; Joseph W Harding
Ethanol-induced suppression of LTP can be attenuated with an angiotensin IV analog.
Regulatory peptides 2003;113(1-3):49-56.
2003: John W Wright; Elizabeth Tamura-Myers; Wendy L Wilson; Bernard P Roques; Catherine Llorens-Cortes; Robert C Speth; Joseph W Harding
Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2003;284(3):R725-33.
2003: John W Wright; Alex J Masino; Jennifer R Reichert; Gary D Turner; Starla E Meighan; Peter C Meighan; Joseph W Harding
Ethanol-induced impairment of spatial memory and brain matrix metalloproteinases.
Brain research 2003;963(1-2):252-61.
2003: Travis E Brown; John W Wright; Robert C Speth
Phospholipase C inhibitor U73122 attenuates the dipsogenic response induced by angiotensin II.
Proceedings of the Western Pharmacology Society 2003;46():61-3.
2003: Robert C Speth; Travis E Brown; Ryan D Barnes; John W Wright
Brain angiotensinergic activity: the state of our current knowledge.
Proceedings of the Western Pharmacology Society 2003;46():11-5.
2002: John W Wright; Jennifer R Reichert; Christopher J Davis; Joseph W Harding
Neural plasticity and the brain renin-angiotensin system.
Neuroscience and biobehavioral reviews 2002;26(5):529-52.
2002: John W Wright; Enikö A Kramár; Starla E Meighan; Joseph W Harding
Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system.
Peptides 2002;23(1):221-46.
2001: Eric S Pederson; R Krishnan; Joseph W Harding; John W Wright
A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits.
Regulatory peptides 2001;102(2-3):147-56.
2001: Matthew J Wayner; Deborah L Armstrong; CF Phelix; John W Wright; Joseph W Harding
Angiotensin IV enhances LTP in rat dentate gyrus in vivo.
Peptides 2001;22(9):1403-14.
2001: T A Hamilton; Rajash K Handa; Joseph W Harding; John W Wright
A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat.
Peptides 2001;22(6):935-44.
2001: Enikö A Kramár; Deborah L Armstrong; S Ikeda; Matthew J Wayner; Joseph W Harding; John W Wright
The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro.
Brain research 2001;897(1-2):114-21.
2000: LT Krebs; JM Hanesworth; MF Sardinia; Robert C Speth; John W Wright; Joseph W Harding
A novel angiotensin analog with subnanomolar affinity for angiotensin-converting enzyme.
The Journal of pharmacology and experimental therapeutics 2000;293(1):260-7.
1999: John W Wright; L Stubley; Eric S Pederson; Enikö A Kramár; JM Hanesworth; Joseph W Harding
Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(10):3952-61.
1999: J H Zhang; JM Hanesworth; MF Sardinia; Jeremy A Alt; John W Wright; Joseph W Harding
Structural analysis of angiotensin IV receptor (AT4) from selected bovine tissues.
The Journal of pharmacology and experimental therapeutics 1999;289(2):1075-83.
1999: R Krishnan; JM Hanesworth; John W Wright; Joseph W Harding
Structure-binding studies of the adrenal AT4 receptor: analysis of position two- and three-modified angiotensin IV analogs.
Peptides 1999;20(8):915-20.
1998: Enikö A Kramár; R Krishnan; Joseph W Harding; John W Wright
Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow.
Regulatory peptides 1998;74(2-3):185-92.
1998: Eric S Pederson; Joseph W Harding; John W Wright
Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog.
Regulatory peptides 1998;74(2-3):97-103.
1998: J K Coleman; LT Krebs; T A Hamilton; B Ong; K A Lawrence; MF Sardinia; Joseph W Harding; John W Wright
Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats.
Peptides 1998;19(2):269-77.
1997: John W Wright; Joseph W Harding
Important role for angiotensin III and IV in the brain renin-angiotensin system.
Brain research. Brain research reviews 1997;25(1):96-124.
1997: Enikö A Kramár; Joseph W Harding; John W Wright
Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes.
Regulatory peptides 1997;68(2):131-8.
1996: L T Krebs; Enikö A Kramár; JM Hanesworth; MF Sardinia; A E Ball; John W Wright; Joseph W Harding
Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist.
Regulatory peptides 1996;67(2):123-30.
1996: S Y Chen; John W Wright; C D Barnes
The neurochemical and behavioral effects of beta-amyloid peptide(25-35).
Brain research 1996;720(1-2):54-60.
1996: John W Wright; JA Clemens; J A Panetta; EB Smalstig; L A Weatherly; Enikö A Kramár; Eric S Pederson; B H Mungall; Joseph W Harding
Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats.
Brain research 1996;717(1-2):1-11.
1996: L Stubley-Weatherly; Joseph W Harding; John W Wright
Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats.
Brain research 1996;716(1-2):29-38.
1996: John W Wright; A J Bechtholt; S L Chambers; Joseph W Harding
Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function.
Peptides 1996;17(8):1365-71.
1996: C M Batt; L L Jensen; Joseph W Harding; John W Wright
Microinfusion of aminopeptidase M into the paraventricular nucleus of the hypothalamus in normotensive and hypertensive rats.
Brain research bulletin 1996;39(4):235-40.
1995: John W Wright; Joseph W Harding
Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions.
Regulatory peptides 1995;59(3):269-95.
1995: K A Roberts; L T Krebs; Enikö A Kramár; M J Shaffer; Joseph W Harding; John W Wright
Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats.
Brain research 1995;682(1-2):13-21.
1995: John W Wright; T A Hamilton; Joseph W Harding
Anomalous effects of losartan on aminopeptidase-induced reductions of blood pressure in SHR.
Brain research bulletin 1995;36(2):169-74.
1995: John W Wright; L T Krebs; J W Stobb; Joseph W Harding
The angiotensin IV system: functional implications.
Frontiers in neuroendocrinology 1995;16(1):23-52.
1994: Joseph W Harding; John W Wright; G N Swanson; JM Hanesworth; L T Krebs
AT4 receptors: specificity and distribution.
Kidney international 1994;46(6):1510-2.
1994: N Ghazi; Kevin L Grove; John W Wright; M I Phillips; Robert C Speth
Variations in angiotensin-II release from the rat brain during the estrous cycle.
Endocrinology 1994;135(5):1945-50.
1994: Wayne S Quirk; J K Coleman; JM Hanesworth; Joseph W Harding; John W Wright
Noise-induced elevations of plasma endothelin (ET-3).
Hearing research 1994;80(1):119-22.
1993: G M McLaren; Wayne S Quirk; Esa Laurikainen; J K Coleman; Michael D Seidman; H A Dengerink; Alfred L Nuttall; Josef M Miller; John W Wright
Substance P increases cochlear blood flow without changing cochlear electrophysiology in rats.
Hearing research 1993;71(1-2):183-9.
1993: A V Miller-Wing; JM Hanesworth; MF Sardinia; K L Hall; John W Wright; Robert C Speth; Kevin L Grove; Joseph W Harding
Central angiotensin IV binding sites: distribution and specificity in guinea pig brain.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1718-26.
1993: John W Wright; A V Miller-Wing; M J Shaffer; Christopher I Higginson; D E Wright; JM Hanesworth; Joseph W Harding
Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory.
Brain research bulletin 1993;32(5):497-502.
1993: John W Wright; K A Roberts; L A Stubley; JM Hanesworth; Joseph W Harding
Hypothalamic angiotensin release in response to AII or glutamic acid stimulation of the SFO in rats.
Brain research bulletin 1993;31(6):649-54.
1993: K A Roberts; John W Wright; Joseph W Harding
GABA and bicuculline-induced blood pressure changes in spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1993;21(1):156-62.
1992: John W Wright; Joseph W Harding
Regulatory role of brain angiotensins in the control of physiological and behavioral responses.
Brain research. Brain research reviews 1992;17(3):227-62.
1992: G N Swanson; JM Hanesworth; MF Sardinia; J K Coleman; John W Wright; K L Hall; A V Miller-Wing; J W Stobb; V I Cook; E C Harding
Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor.
Regulatory peptides 1992;40(3):409-19.
1992: Joseph W Harding; V I Cook; A V Miller-Wing; JM Hanesworth; MF Sardinia; K L Hall; J W Stobb; G N Swanson; J K Coleman; John W Wright
Identification of an AII(3-8) [AIV] binding site in guinea pig hippocampus.
Brain research 1992;583(1-2):340-3.
1992: L L Jensen; Joseph W Harding; John W Wright
Role of paraventricular nucleus in control of blood pressure and drinking in rats.
The American journal of physiology 1992;262(6 Pt 2):F1068-75.
1992: Joseph W Harding; L L Jensen; JM Hanesworth; K A Roberts; T A Page; John W Wright
Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli.
The American journal of physiology 1992;262(1 Pt 2):F17-23.
1991: J K Coleman; H A Dengerink; John W Wright
Effects of hydroxyethyl starch, nimodipine, and propylene glycol on cochlear blood flow.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1991;105(6):840-4.
1991: John W Wright; H Z Amir; C E Murray; K A Roberts; Joseph W Harding; S Mizutani; P E Ward
Use of aminopeptidase M as a hypotensive agent in spontaneously hypertensive rats.
Brain research bulletin 1991;27(5):545-51.
1991: G M McLaren; J K Coleman; Wayne S Quirk; H A Dengerink; John W Wright
The influence of intra-arterial infusion of arginine vasopressin on cochlear blood flow in the rat.
Hearing research 1991;55(1):1-8.
1991: C E Murray; Joseph W Harding; John W Wright
Hypotensive effects of sarthran in normotensive and spontaneously hypertensive rat strains.
Pharmacology, biochemistry, and behavior 1991;39(4):1029-32.
1991: J L Banasik; Howard L Hosick; John W Wright; Joseph W Harding
Endothelin binding in brain of normotensive and spontaneously hypertensive rats.
The Journal of pharmacology and experimental therapeutics 1991;257(1):302-6.
1991: G M McLaren; H A Dengerink; P A Hellström; John W Wright
Effects of perilymph volume adjustments on cochlear blood flow in the guinea pig.
Acta oto-laryngologica 1991;111(1):94-100.
1990: A J Flynn; H A Dengerink; John W Wright
Androgenic effects on angiotensin II-induced blood pressure and cochlear blood flow changes in rats.
Hearing research 1990;50(1-2):119-25.
1990: V I Cook; John W Wright; S A Wright; Joseph W Harding
Comparison of angiotensin metabolism by brain membranes from SHR and WKY rats.
Brain research 1990;529(1-2):320-3.
1990: C M Batt; L L Jensen; JM Hanesworth; Joseph W Harding; John W Wright
Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.
Brain research 1990;529(1-2):126-30.
1990: John W Wright; S Mizutani; C E Murray; H Z Amir; Joseph W Harding
Aminopeptidase-induced elevations and reductions in blood pressure in the spontaneously hypertensive rat.
Journal of hypertension 1990;8(10):969-74.
1990: J K Coleman; Wayne S Quirk; H A Dengerink; John W Wright
Pentoxifylline increases cochlear blood flow while decreasing blood pressure in guinea pigs.
Hearing research 1990;47(1-2):169-74.
1990: Wayne S Quirk; H A Dengerink; M J Bademian; John W Wright
Mannitol and dextran increase cochlear blood flow in normotensive and spontaneously hypertensive rats.
Acta oto-laryngologica 1990;109(5-6):383-8.
1990: John W Wright; K A Roberts; V I Cook; C E Murray; MF Sardinia; Joseph W Harding
Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
Brain research 1990;514(1):5-10.
1989: John W Wright; L L Jensen; K A Roberts; MF Sardinia; Joseph W Harding
Structure-function analyses of brain angiotensin control of pressor action in rats.
The American journal of physiology 1989;257(6 Pt 2):R1551-7.
1989: A J Flynn; Wayne S Quirk; H A Dengerink; John W Wright
The effects of intracerebroventricularly administered angiotensin II on blood pressure and cochlear blood flow in rats and guinea pigs.
Hearing research 1989;41(2-3):249-54.
1989: Wayne S Quirk; H A Dengerink; J K Coleman; John W Wright
Cochlear blood flow autoregulation in Wistar-Kyoto rats.
Hearing research 1989;41(1):53-60.
1989: L L Jensen; Joseph W Harding; John W Wright
Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains.
Brain research 1989;490(1):48-55.
1989: John W Wright; L L Jensen; L L Cushing; Joseph W Harding
Leucine aminopeptidase M-induced reductions in blood pressure in spontaneously hypertensive rats.
Hypertension 1989;13(6 Pt 2):910-5.
1989: Joseph W Harding; L L Jensen; Wayne S Quirk; A L Dewey; John W Wright
Brain angiotensin: critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function.
Peptides 1989;10(2):261-4.
1989: Wayne S Quirk; H A Dengerink; Joseph W Harding; M J Bademian; S J Swanson; John W Wright
Autoregulation of cochlear blood flow in normotensive and spontaneously hypertensive rats following intracerebroventricularly mediated adjustment of blood pressure.
Hearing research 1989;38(1-2):119-23.
1988: C M Batt; E W Klein; Joseph W Harding; John W Wright
Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran.
Brain research bulletin 1988;21(5):731-5.
1988: Wayne S Quirk; H A Dengerink; M J Bademian; K W Hall; John W Wright
The effects of pentoxifylline on cochlear blood flow in normotensive and spontaneously hypertensive rats.
Hearing research 1988;36(2-3):175-80.
1988: John W Wright; K A Roberts; Joseph W Harding
Drinking to intracerebroventricularly infused angiotensin II, III, and IV in the SHR.
Peptides 1988;9(5):979-84.
1988: M J Sullivan; Joseph W Harding; John W Wright
Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses.
Brain research 1988;456(2):249-53.
1988: A J Flynn; H A Dengerink; John W Wright
Blood pressure in resting, anesthetized and noise-exposed guinea pigs.
Hearing research 1988;34(2):201-5.
1988: G R Laugel; John W Wright; H A Dengerink
Angiotensin II and progesterone effects on laser Doppler measures of cochlear blood flow.
Acta oto-laryngologica 1988;106(1-2):34-9.
1988: Wayne S Quirk; John W Wright; Joseph W Harding
Tachyphylaxis of dipsogenic activity to intracerebroventricular administration of angiotensins.
Brain research 1988;452(1-2):73-8.
1988: John W Wright; L L Jensen; L L Cushing; Joseph W Harding
Heightened blood pressure responsiveness to intracarotid infusion of angiotensins in the spontaneously hypertensive rat.
Pharmacology, biochemistry, and behavior 1988;30(2):343-6.
1988: A L Dewey; John W Wright; JM Hanesworth; Joseph W Harding
Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat.
Brain research 1988;448(2):369-72.
1988: L L Jensen; Joseph W Harding; John W Wright
Central effects of a specific angiotensin receptor antagonist, sarthran (Sar1, Thr8AII) in normotensive and spontaneously hypertensive rat strains.
Brain research 1988;448(2):359-63.
1988: Wayne S Quirk; John W Wright; H A Dengerink; Josef M Miller
Angiotensin II-induced changes in cochlear blood flow and blood pressure in normotensive and spontaneously hypertensive rats.
Hearing research 1988;33(2):129-35.
1988: John W Wright; Wayne S Quirk; JM Hanesworth; Joseph W Harding
Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats.
Brain research 1988;441(1-2):215-20.
1988: Joseph W Harding; M J Sullivan; JM Hanesworth; L L Cushing; John W Wright
Inability of [125I]Sar1, Ile8-angiotensin II to move between the blood and cerebrospinal fluid compartments.
Journal of neurochemistry 1988;50(2):554-7.
1987: G R Laugel; H A Dengerink; John W Wright
Ovarian steroid and vasoconstrictor effects on cochlear blood flow.
Hearing research 1987;31(3):245-51.
1987: John W Wright; M J Sullivan; Wayne S Quirk; C M Batt; Joseph W Harding
Heightened blood pressure and drinking responsiveness to intracerebroventricularly applied angiotensins in the spontaneously hypertensive rat.
Brain research 1987;420(2):289-94.
1987: R H Abhold; M J Sullivan; John W Wright; Joseph W Harding
Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
The Journal of pharmacology and experimental therapeutics 1987;242(3):957-62.
1987: John W Wright; M J Sullivan; C R Bredl; JM Hanesworth; L L Cushing; Joseph W Harding
Delayed cerebroventricular metabolism of [125I]angiotensins in the spontaneously hypertensive rat.
Journal of neurochemistry 1987;49(2):651-4.
1987: Wayne S Quirk; Joseph W Harding; John W Wright
Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
Brain research bulletin 1987;19(1):145-7.
1986: John W Wright; M J Sullivan; Wayne S Quirk; C M Batt; Joseph W Harding
Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1986;4(6):S408-11.